Final approved 5 point oct 14 2010
41
-
Upload
miguel-paneke -
Category
Documents
-
view
346 -
download
1
description
Make the most of the anti-aging revolution and facebook are multimillion dollar companies in their growth momentum and you grow when you know how to use and when is the time. now. pienc but not now. earn money and years to live young.
Transcript of Final approved 5 point oct 14 2010
![Page 2: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/2.jpg)
![Page 3: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/3.jpg)
![Page 4: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/4.jpg)
![Page 5: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/5.jpg)
![Page 6: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/6.jpg)
WE HAVE UNIQUE, PATENTED, AND EXCLUSIVE
Anti-Aging TECHNOLOGIES.
LOOKING YOUNGER! FEELING YOUNGER!
ageLOC
GALVANIC SPA SYSTEM
ageLOC ELEMENTS
AND FUTURE SERUM
ageLOC VITALITY
ageLOC
Future Serum
RESET, REVIVE, RENEW
- Physical Vigor
- Mental Acuity
- Sexual Drive
ageLOC Elements
VISUAL EMOTIONAL CONSUMABLE
![Page 7: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/7.jpg)
![Page 8: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/8.jpg)
![Page 9: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/9.jpg)
![Page 10: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/10.jpg)
![Page 11: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/11.jpg)
![Page 12: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/12.jpg)
![Page 13: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/13.jpg)
Beijing Clinical CenterBeijing Clinical Center Huzhou Mfr. PlantHuzhou Mfr. PlantShanghai R&D CenterShanghai R&D Center
Provo, Utah Headquarters &
Pharmanex Research Institute
Provo, Utah Headquarters &
Pharmanex Research Institute
![Page 14: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/14.jpg)
![Page 15: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/15.jpg)
![Page 16: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/16.jpg)
![Page 17: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/17.jpg)
![Page 18: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/18.jpg)
![Page 19: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/19.jpg)
![Page 20: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/20.jpg)
![Page 21: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/21.jpg)
![Page 22: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/22.jpg)
![Page 23: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/23.jpg)
![Page 24: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/24.jpg)
![Page 25: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/25.jpg)
First wave ageLOC Gels
![Page 26: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/26.jpg)
Second wave Feb. 2010:
Transformatión.
![Page 27: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/27.jpg)
Third Wave Oct 2010
Energy, Mental Sharpness, Sexual Libido
![Page 28: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/28.jpg)
![Page 29: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/29.jpg)
![Page 30: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/30.jpg)
![Page 31: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/31.jpg)
![Page 32: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/32.jpg)
![Page 33: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/33.jpg)
![Page 34: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/34.jpg)
![Page 35: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/35.jpg)
![Page 36: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/36.jpg)
![Page 37: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/37.jpg)
![Page 38: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/38.jpg)
![Page 39: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/39.jpg)
![Page 40: Final approved 5 point oct 14 2010](https://reader035.fdocuments.net/reader035/viewer/2022062708/55898badd8b42aea4a8b4713/html5/thumbnails/40.jpg)